FOR IMMEDIATE RELEASE: JULY 1, 2020
370 Old Country Rd. Suite 100
Garden City, NY 11530
PRINE Health Nephrology Group Expands Further Beyond the Kidney
Garden City, NY: Today, PRINE Health Nephrology expands its practice, with plans to launch two new divisions, PRINE Vascular and PRINE Podiatry. In September, PRINE is set to open a full-service Vascular Lab at Parker Jewish Institute in New Hyde Park, NY. PRINE Health cares for a large kidney patient population, but the vascular initiative will not be limited to dialysis access. Due to the high incidence of peripheral vascular disease in this population, there will be an emphasis on PVD, wound care, and cutting-edge, interventional procedures. The new Chief of PRINE Vascular is Dr. Daniel Simon, a highly skilled Interventional Radiologist who was a past Co-Chief of Interventional Radiology at Northwell’s North Shore University Hospital in Manhasset. PRINE has also signed Dr. Robyn Joseph, a prominent local podiatrist, to become the Chief of PRINE Podiatry for this complementary division which is planned to go-live in October.
PRINE Health is led by the former CEO of Beacon Health Partners, Dr. Simon Prince, a nephrologist with experience in population health and provider networks. Dr. Prince said, “we are just getting going. Everyone at PRINE is excited about our new vascular and podiatry initiatives, as well as our potential to innovate and elevate the care we deliver to this often overlooked vulnerable patient population.”
PRINE Health, with its tagline, Primary Nephrology is a unique, multispecialty medical group focused around chronic kidney disease. PRINE launched last year with the merger of 6 independent nephrology groups to become the largest independent nephrology group in New York. In addition to the nephrologists, interventional radiologists, and podiatrists, PRINE has brought in seasoned primary care physicians and is involved in multiple ongoing conversations with other complementary specialties. There are currently 9 office locations and 18 dialysis center affiliations in Long Island and Queens.
PRINE also has a management company (MSO) that is owned and governed by the physicians. The MSO provides traditional practice management and population health services to the medical group. Over the last several months, PRINE has developed care management capabilities and several strategic relationships. PRINE has partnered with managed care payors and was recently selected by CMS to participate in a new value-based kidney care program, Kidney Care First in 2021. Additionally, PRINE has partnered with the data scientists at pulse data to use predictive analytics and artificial intelligence on their growing patient population as efforts are being made to get ready to take risks in this complex, costly CKD/ESRD population.
To find out more about PRINE, visit www.prinehealth.com.